BridgeBio Pharma Inc (BBIO)

BridgeBio Pharma (BBIO) Balance Sheet


BridgeBio Pharma Balance Sheet

BridgeBio Pharma's total assets for Q4 2023 were $546.38M, a decrease of -16.58% from the previous quarter. BBIO total liabilities were $1.89B for the fiscal quarter, a 2.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 546.38M$ 623.04M$ 1.01B$ 703.59M$ 631.68M
Total Liabilities
$ 1.89B$ 589.75M$ 606.74M$ 595.70M$ 157.95M
Total Equity Gross Minority
$ -1.34B$ -1.24B$ -867.00M$ 107.89M$ 473.73M
Total Capitalization
$ -452.39M$ -380.36M$ -439.66M$ 533.76M$ 500.25M
Preferred Stock Equity
Capital Lease Obligations
---$ 18.47M$ 0.00
Currency in USD

BridgeBio Pharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis